115 related articles for article (PubMed ID: 2751753)
1. Effect of pindolol versus atenolol on lipid profile in hypertensive patients.
Notghi A; Riemersma RA; Anderton JL; Oliver MF
Atherosclerosis; 1989 Jun; 77(2-3):215-20. PubMed ID: 2751753
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients.
Lehtonen A
Cardiovasc Drugs Ther; 1988 Jan; 1(5):549-51. PubMed ID: 3154682
[TBL] [Abstract][Full Text] [Related]
3. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
Floras JS; Jones JV; Hassan MO; Sleight P
Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
[TBL] [Abstract][Full Text] [Related]
4. Beta-adrenoceptor blockade and plasma lipoproteins. Comparison of the effects of propranolol and pindolol on plasma lipoproteins including high-density lipoprotein subfractions.
Northcote RJ; Ballantyne D
Clin Sci (Lond); 1987 May; 72(5):549-56. PubMed ID: 3581681
[TBL] [Abstract][Full Text] [Related]
5. Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men.
Durrington PN; Brownlee WC; Large DM
Clin Sci (Lond); 1985 Dec; 69(6):713-9. PubMed ID: 2866062
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the side-effects of pindolol and atenolol in the treatment of hypertension.
Abrahamsen AM; Digranes O; Gisholt K
J Intern Med; 1990 Sep; 228(3):219-22. PubMed ID: 2205704
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
van den Meiracker AH; Man in 't Veld AJ; van Eck HJ; Boomsma F; Schalekamp MA
Circulation; 1988 Oct; 78(4):957-68. PubMed ID: 3048776
[TBL] [Abstract][Full Text] [Related]
8. Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris.
Antalóczy Z; Kekes E
Zhongguo Yao Li Xue Bao; 1989 May; 10(3):222-6. PubMed ID: 2609991
[TBL] [Abstract][Full Text] [Related]
9. [Comparative effects of pindolol and atenolol on blood pressure and lipids in mild to moderate arterial hypertension].
Herpin D; Guillard O; Piriou A; Amiel A; Boutaud P; Ciber MA; Demange J
Ann Med Interne (Paris); 1988; 139(7):484-7. PubMed ID: 3072894
[TBL] [Abstract][Full Text] [Related]
10. Beta-blockade with intrinsic sympathetic activity modifies favorably exercise-induced changes in plasma lipoproteins.
Van Nguyen P; Cleroux J; Peterson M; Leenen FH
J Appl Physiol (1985); 1990 Aug; 69(2):485-9. PubMed ID: 1977731
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of pindolol and atenolol on hemodynamic function in systemic hypertension.
Toth PD; Demeter RJ; Woods JR; Nyhuis AW; Judy WV
Am J Cardiol; 1988 Sep; 62(7):413-8. PubMed ID: 3414518
[TBL] [Abstract][Full Text] [Related]
12. Effect of pindolol on serum lipoproteins in patients with coronary heart disease.
Karmakoski J; Viikari J; Rönnemaa T
Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):189-91. PubMed ID: 6862723
[TBL] [Abstract][Full Text] [Related]
13. Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics.
Montan S; Ingemarsson I; Marsál K; Sjöberg NO
BMJ; 1992 Apr; 304(6832):946-9. PubMed ID: 1581716
[TBL] [Abstract][Full Text] [Related]
14. Effect of beta blockers on blood lipid profile.
Lehtonen A
Am Heart J; 1985 May; 109(5 Pt 2):1192-6. PubMed ID: 2859784
[TBL] [Abstract][Full Text] [Related]
15. Changes in blood pressure, heart rate and thyroid hormones after sudden withdrawal of pindolol and atenolol in hypertensive patients.
Jespersen CM; Jørgensen PH; Krogsgaard AR; Friis T
Scand J Clin Lab Invest; 1986 Nov; 46(7):615-21. PubMed ID: 3538363
[TBL] [Abstract][Full Text] [Related]
16. Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication.
Roberts DH; Tsao Y; McLoughlin GA; Breckenridge A
Lancet; 1987 Sep; 2(8560):650-3. PubMed ID: 2887941
[TBL] [Abstract][Full Text] [Related]
17. Lipids and lipoproteins during antihypertensive drug therapy. Comparison of doxazosin and atenolol in a randomized, double-blind trial: the Alpha Beta Canada Study.
Rabkin SW; Huff MW; Newman C; Sim D; Carruthers SG
Hypertension; 1994 Aug; 24(2):241-8. PubMed ID: 8039850
[TBL] [Abstract][Full Text] [Related]
18. Effect of beta-blockers on plasma lipids.
Pasotti C; Zoppi A; Capra A; Rebagliati M; Fogari R
Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):448-52. PubMed ID: 3759280
[TBL] [Abstract][Full Text] [Related]
19. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
McNeil JJ; Louis WJ
Br J Clin Pharmacol; 1979; 8(Suppl 2):163S-166S. PubMed ID: 43164
[TBL] [Abstract][Full Text] [Related]
20. Effect of metoprolol and pindolol monotherapy on plasma lipid- and lipoprotein-cholesterol levels (including the HDL subclasses) in mild hypertensive males and females.
Szollár LG; Mészáros I; Tornóci L; Rischák K; Molnár M; Mányai S
J Cardiovasc Pharmacol; 1990 Jun; 15(6):911-7. PubMed ID: 1694913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
